Attached files
file | filename |
---|---|
EX-99.5 - UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL STATEMENTS OF THE COMPANY AND N - Boston Therapeutics, Inc. | ea145852ex99-5_bostontherap.htm |
EX-99.4 - UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS OF NANOMIX AS OF MARCH 31, - Boston Therapeutics, Inc. | ea145852ex99-4_bostontherap.htm |
EX-99.3 - AUDITED FINANCIAL STATEMENTS OF NANOMIX AS OF AND FOR THE YEARS ENDED DECEMBER 3 - Boston Therapeutics, Inc. | ea145852ex99-3_bostontherap.htm |
EX-99.2 - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERA - Boston Therapeutics, Inc. | ea145852ex99-2_bostontherap.htm |
EX-99.1 - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERA - Boston Therapeutics, Inc. | ea145852ex99-1_bostontherap.htm |
Loading Inline Form.
Settings